Sanguinarine Triggers Apoptosis in Cutaneous Squamous Cell Carcinoma Cells through Reactive Oxygen Species-Dependent c-Jun N-Terminal Kinase Signaling Pathway
Frontiers in Bioscience-Landmark · 2024
DOI: 10.31083/j.fbl2901040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Kalyani Patil und 10 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Institute, Academic Health System, Hamad Medical Corporation, 2030 Doha, Qatar. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Skin Neoplasms, Anthracenes, Isoquinolines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Center, Hamad Medical Corporation.
Abstract (Originalsprache)
Background
The benzophenanthridine Sanguinarine (Sng) is one of the most abundant root alkaloids with a long history of investigation and pharmaceutical applications. The cytotoxicity of Sng against various tumor cells is well-established; however, its antiproliferative and apoptotic potential against the cutaneous squamous cell carcinoma (cSCC) cells remains unknown. In the present study, we investigated the anti-cancer potential of Sng against cSCC cells and elucidated the underlying mechanisms relevant to the drug action.
Methods
The inhibitory effect of Sng on cSCC cells was evaluated by analyzing cell viability, colony-forming ability and multi-caspase activity. Apoptosis was quantified through Annexin-V/Propidium iodide flow cytometric assay and antagonized by pan-caspase inhibitor z-VAD-FMK. Mitochondrial membrane potential (ΔΨm) dysfunction was analyzed by JC-1 staining, whereas reactive oxygen species (ROS) generation was confirmed by pretreatment with N-acetylcysteine (NAC) and fluorogenic probe-based flow cytometric detection. The expression of cell cycle regulatory proteins, apoptotic proteins and MAPK signaling molecules was determined by Western blotting. Involvement of JNK, p38-MAPK and MEK/ERK in ROS-mediated apoptosis was investigated by pretreatment with SP600125 (JNK inhibitor), SB203580 (p38 inhibitor) and U0126 (ERK1/2 inhibitor), respectively. The stemness-targeting potential of Sng was assessed in tumor cell-derived spheroids.
Results
Treatment with Sng decreased cell viability and colony formation in primary (A431) and metastatic (A388) cSCC cells in a time- and dose-dependent manner. Sng significantly inhibited cell proliferation by inducing sub-G0/G1 cell-cycle arrest and apoptosis in cSCC cells. Sng evoked ROS generation, intracellular glutathione (GSH) depletion, ΔΨm depolarization and the activation of JNK pathway as well as that of caspase-3, -8, -9, and PARP. Antioxidant NAC inhibited ROS production, replenished GSH levels, and abolished apoptosis induced by Sng by downregulating JNK. Pretreatment with z-VAD-FMK inhibited Sng-mediated apoptosis. The pharmacological inhibition of JNK by SP600125 mitigated Sng-induced apoptosis in metastatic cSCC cells. Finally, Sng ablated the stemness of metastatic cSCC cell-derived spheroids.
Conclusion
Our results indicate that Sng exerts a potent cytotoxic effect against cSCC cells that is underscored by a mechanism involving multiple levels of cooperation, including cell-cycle sub-G0/G1 arrest and apoptosis induction through ROS-dependent activation of the JNK signaling pathway. This study provides insight into the potential therapeutic application of Sng targeting cSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Research Institute, Academic Health System, Hamad Medical Corporation, 2030 Doha, Qatar.
- Dermatology Institute, Academic Health System, Hamad Medical Corporation, 2030 Doha, Qatar.
- Department of Human Genetics-Precision Medicine in Diabetes, Obesity and Cancer Research Program, Sidra Medicine, 26999 Doha, Qatar.
- Department of Dermatology and Venereology, Rumailah Hospital, Hamad Medical Corporation, 3050 Doha, Qatar.
- Department of Medicine, Weill Cornell Medicine Qatar, Qatar Foundation-Education City, 24144 Doha, Qatar.
- Department of Medicine, Weill Cornell Medicine Qatar, New York, NY 10065, USA.
Förderung
- Medical Research Center, Hamad Medical Corporation
Zitieren
APA
Patil, K., Khan, A. Q., Ahmad, F., Kuttikrishnan, S., Anver, R., Mateo, J. M., Ahmad, A., Bhat, A. A., Buddenkotte, J., Steinhoff, M., & Uddin, S. (2024). Sanguinarine Triggers Apoptosis in Cutaneous Squamous Cell Carcinoma Cells through Reactive Oxygen Species-Dependent c-Jun N-Terminal Kinase Signaling Pathway. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2901040
Vancouver
Patil K, Khan AQ, Ahmad F, Kuttikrishnan S, Anver R, Mateo JM, et al. Sanguinarine Triggers Apoptosis in Cutaneous Squamous Cell Carcinoma Cells through Reactive Oxygen Species-Dependent c-Jun N-Terminal Kinase Signaling Pathway. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2901040
BibTeX
@article{Patil2024,
author = {Patil, Kalyani and Khan, Abdul Q and Ahmad, Fareed and Kuttikrishnan, Shilpa and Anver, Rasheeda and Mateo, Jericha M and Ahmad, Aamir and Bhat, Ajaz A and Buddenkotte, Joerg and Steinhoff, Martin and Uddin, Shahab},
title = {Sanguinarine Triggers Apoptosis in Cutaneous Squamous Cell Carcinoma Cells through Reactive Oxygen Species-Dependent c-Jun N-Terminal Kinase Signaling Pathway},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2901040}
}
EUVIMED